$100 Invested In Keysight Technologies 5 Years Ago Would Be Worth This Much Today

  Keysight Technologies (NYSE:KEYS) has outperformed the market over the past 5 years by 21.41% on an annualized basis producing an average annual return of 33.1%. Currently, Keysight Technologies has a market capitalization of $30.29 billion.

 

Keysight Technologies (NYSE:KEYS) has outperformed the market over the past 5 years by 21.41% on an annualized basis producing an average annual return of 33.1%. Currently, Keysight Technologies has a market capitalization of $30.29 billion.

Buying $100 In KEYS: If an investor had bought $100 of KEYS stock 5 years ago, it would be worth $421.67 today based on a price of $168.33 for KEYS at the time of writing.

Keysight Technologies’s Performance Over Last 5 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Genetic Technologies Announced Partnership With Siles Health to Bring GeneType Risk Test to 9 Clinics

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company", "GTG"), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce that we are partnering with Melbourne based Siles Health, a leading Obstetrics and Gynaecology practice, to implement geneType Multi-Risk Test as part of their commitment to remain at the forefront of contemporary personal

GENE